Detail page

Knowledge Web

Person

Markus Hartenbach (1978-)

Arzt

Name	Markus Hartenbach
Time	1978- (Date of birth and death)
Place	Wien (Wirkungsort) Ulm (Wirkungsort) Österreich Deutschland
Gender	männlich
Academic degree	Prof. Dr. med.
Profession	Arzt (characteristic profession) Nuklearmediziner
Variant	M. Hartenbach
Related	Universitätsklinik für Radiologie und Nuklearmedizin (Wien) (2013-2018)
Further information	Studium der Medizin an der Universität Ulm; Promotion 2006
Source	https://www.minute-medical.com/team-de/ (Stand: 03.03.2022)
Record type	Person
GND-Identifier	132349310
Record ID	132349310
Involved in show all Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks Prospective evaluation of the performance of [68Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomy Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer [18F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery Task-relevant brain networks identified with simultaneous PET/MR imaging of metabolism and connectivity 68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy – diagnostic performance and impact on therapeutic decision-making Quantitative assessment of atherosclerotic plaques on 18F-FDG PET/MRI: comparison with a PET/CT hybrid system Primär lokalisiertes Prostatakarzinom : Vergleich der non-invasiven Diagnostik mittels präoperativer C-Cholin-PET-CT-Untersuchung und postoperativen (histologisch gesicherten) Ergebnissen Primär lokalisiertes Prostatakarzinom : Vergleich der non-invasiven Diagnostik mittels präoperativer 11C-Cholin-PET-CT-Untersuchung und postoperativen (histologisch gesicherten) Ergebnissen

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Markus Hartenbach (1978-)

Supervised machine learning enables non-invasive lesion characterization in primary prostate cancer with [68Ga]Ga-PSMA-11 PET/MRI

Clinical outcome of standardized 177Lu-PSMA-617 therapy in metastatic prostate cancer patients receiving 7400 MBq every 4 weeks

Prospective evaluation of the performance of [68Ga]Ga-PSMA-11 PET/CT(MRI) for lymph node staging in patients undergoing superextended salvage lymph node dissection after radical prostatectomy

Response assessment using 68Ga-PSMA ligand PET in patients undergoing 177Lu-PSMA radioligand therapy for metastatic castration-resistant prostate cancer

[18F]DOPA PET/ceCT in diagnosis and staging of primary medullary thyroid carcinoma prior to surgery

Task-relevant brain networks identified with simultaneous PET/MR imaging of metabolism and connectivity

68Ga-PSMA 11 ligand PET imaging in patients with biochemical recurrence after radical prostatectomy – diagnostic performance and impact on therapeutic decision-making

Quantitative assessment of atherosclerotic plaques on 18F-FDG PET/MRI: comparison with a PET/CT hybrid system

Primär lokalisiertes Prostatakarzinom : Vergleich der non-invasiven Diagnostik mittels präoperativer C-Cholin-PET-CT-Untersuchung und postoperativen (histologisch gesicherten) Ergebnissen

Primär lokalisiertes Prostatakarzinom : Vergleich der non-invasiven Diagnostik mittels präoperativer 11C-Cholin-PET-CT-Untersuchung und postoperativen (histologisch gesicherten) Ergebnissen